Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.

Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.

Abstract: The invention inter alia relates to a balanced frequency doubler comprising a first frequency doubler unit providing a first input port and a second input port, a second frequency doubler unit providing a third input port and a fourth input port, wherein the first, second, third and fourth input port are configured to receive a first, second, third and fourth input signal, respectively, wherein the first, second, third and fourth input signals all have the same first harmonic frequency, but are phase-shifted relative to one another, wherein a first current, the frequency spectrum of which comprises a second harmonic frequency that is double the first harmonic frequency, is driven through the first frequency doubler unit in response to the first and second input signal, wherein a second current, the frequency spectrum of which also comprises the second harmonic frequency, is driven through the second frequency doubler unit in response to the third and fourth input signals, and wherein a balanced output signal

Abstract: The invention inter alia relates to a balanced frequency doubler comprising a first frequency doubler unit providing a first input port and a second input port, a second frequency doubler unit providing a third input port and a fourth input port, wherein the first, second, third and fourth input port are configured to receive a first, second, third and fourth input signal, respectively, wherein the first, second, third and fourth input signals all have the same first harmonic frequency, but are phase-shifted relative to one another, wherein a first current, the frequency spectrum of which comprises a second harmonic frequency that is double the first harmonic frequency, is driven through the first frequency doubler unit in response to the first and second input signal, wherein a second current, the frequency spectrum of which also comprises the second harmonic frequency, is driven through the second frequency doubler unit in response to the third and fourth input signals, and wherein a balanced output signal

Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.

Abstract: A nebulizer for a fluid, particularly for medical aerosol treatment is proposed. To allow easier operation and confer improved operational reliability a sealed container holding the fluid is already arranged in the nebulizer when it is supplied and the nebulizer is constructed so that the container is opened inside the nebulizer before or during the first use of the nebulizer. For this purpose, a transportation lock is provided for the sealed container which, in the delivery state, is in engagement with the sealed container in a manner preventing the sealed container from moving axially in the nebulizer.

Abstract: A circuit arrangement for a front end of an FMCW radar transceiver, with a signal terminal that is configured so as to couple to a signal filter device for purposes of signal exchange, a further signal terminal that is configured so as to couple to a VCO device for purposes of signal exchange, and an electronic circuit, which with the aid of a switching device included in the electronic circuit can be switched over between a reception circuit configuration and a transmission circuit configuration, is disclosed. The switching device has an RF switch, with which a signal route formed respectively in the RF switch, is embodied asymmetrically, in that the signal route in a reception circuit configuration and the signal route in a transmission circuit configuration have a different number of switching stages. A FMCW radar transceiver, and a method for the operation of a front end are also disclosed.

Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and metformin XR (extended release), processes for the preparation thereof, and their use to treat certain diseases.

Abstract: The invention relates to new pharmaceutical compositions for the treatment of sexual disorders and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient selected from the group consisting of compounds used for female hormone replacement therapy 2a, compounds used for menopause problems 2b, and contraceptives 2c.

Abstract: The invention relates to a new medicament formulation of the active substance dabigatran etexilate of formula I optionally in the form of the pharmaceutically acceptable salts thereof, as well as the preparation thereof.

Abstract: The present disclosure pertains to a transmitter for waking up electronic systems with a first signal generator which is designed to generate a carrier signal with a first frequency, a second signal generator which is designed to generate an informational signal with a second frequency, a single-sideband modulator which is designed to modulate the information signal by the carrier signal, and a transmission device which is designed to emit the generated carrier signal and the modulated information signal. The present disclosure also pertains to a receiver, an aircraft and spacecraft and a method.

Abstract: A circuit arrangement for a front end of an FMCW radar transceiver, with a signal terminal that is configured so as to couple to a signal filter device for purposes of signal exchange, a further signal terminal that is configured so as to couple to a VCO device for purposes of signal exchange, and an electronic circuit, which with the aid of a switching device included in the electronic circuit can be switched over between a reception circuit configuration and a transmission circuit configuration, is disclosed. The switching device has an RF switch, with which a signal route formed respectively in the RF switch, is embodied asymmetrically, in that the signal route in a reception circuit configuration and the signal route in a transmission circuit configuration have a different number of switching stages. A FMCW radar transceiver, and a method for the operation of a front end are also disclosed.

Abstract: A nebulizer for a fluid, particularly for medical aerosol treatment is proposed. To allow easier operation and confer improved operational reliability a sealed container holding the fluid is already arranged in the nebulizer when it is supplied and the nebulizer is constructed so that the container is opened inside the nebulizer before or during the first use of the nebulizer. For this purpose, a transportation lock is provided for the sealed container which, in the delivery state, is in engagement with the sealed container in a manner preventing the sealed container from moving axially in the nebulizer.

Abstract: An atomizer and a method of dispensing and atomizing fluid into individual containers through a nozzle are proposed, where in order to improve the dosing accuracy, a preliminary amount of fluid, flushing the nozzle, is dispensed before each dose is dispensed.

Abstract: A nebulizer for a fluid, particularly for medical aerosol treatment is proposed. To allow easier operation and confer improved operational reliability a sealed container holding the fluid is already arranged in the nebulizer when it is supplied and the nebulizer is constructed so that the container is opened inside the nebulizer before or during the first use of the nebulizer. Alternatively, or in addition, the nebulizer is constructed so that the container cannot be replaced, and in particular, cannot be removed.

Abstract: The invention relates to a new medicament formulation of the active substance dabigatran etexilate of formula I optionally in the form of the pharmaceutically acceptable salts thereof, as well as the preparation thereof.

Abstract: The present invention relates to a multiple unit pellet system (MUPS) in form of a tablet containing a pharmaceutically active ingredient, characterized in that the MUPS is an optionally coated immediate release pharmaceutical dosage form for oral administration.

Abstract: An atomizer for a fluid, in particular, a fluid for medical aerosol therapy. In order to allow simplified operation and improved safety in use, the atomizer has a counter device for counting the number of operations of the atomizer and the number of containers inserted. The atomizer is locked against further operation and/or against removal of the current container or insertion of a new container, if a certain number of operations of the atomizer and/or a certain number of containers inserted has/have been reached or exceeded.

Abstract: A process and a device for dosing a pharmaceutical agent, preferably a liquid, are proposed. To achieve an enhanced dosing accuracy, a first component that is produced in batches, such as a shaped seal, is combined with a second component, such as a guide pipe selected from a suitable group guide pipes, wherein the suitable group of second components is selected based on at least one decisively significant value of the respective batch first components and is distinguished by an essential value of the second component which will optimize the sealing between the first and second components.

Abstract: The invention relates to a powder inhaler (1) with mouthpiece (2) for dispersing pharmaceutical medicament formulations, which comprises an auxiliary energy source in the form of a pressure medium system (3), having a device for supplying (6) a powder formulation (7), while on activation of the pressure medium system a gaseous pressure medium (8) released by the pressure medium system (3) forms an aerosol (9) with the powder formulation (7) such that the powder particles are present in the gaseous pressure medium (8) in dispersed form. This is achieved by means of a powder inhaler (1) comprising a multi-channel nozzle, the channels of which are inclined to one another at an angle such that the aerosol jets flowing through them meet one another downstream behind the nozzle (10).